MedTrace Logo

Clinical Evaluation of Investigational Contact Lenses

NCT02801396 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2017-07-11

Study results available
· View outcomes & findings →

Summary

Single-visit, unmasked, non-dispensing study where subjects will wear three different lenses bilaterally in one visit, each lens being worn for approximately 30-60 minutes. Subjects will complete a questionnaire for each study lens.

Conditions

  • Visual Acuity

Interventions

DEVICE

Etafilcon A Design 1 (Test 1)

DEVICE

Etafilcon A Design 2 (Test 2)

DEVICE

Etafilcon A (Control)

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-24
Primary Completion
2016-05-22
Completion
2016-05-22
FDA Device
Yes

Countries

  • Hong Kong

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02801396 on ClinicalTrials.gov